| Product NDC: | 52544-920 |
| Proprietary Name: | OXYTROL |
| Non Proprietary Name: | Oxybutynin |
| Active Ingredient(s): | 3.9 mg/d & nbsp; Oxybutynin |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-920 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021351 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030226 |
| Package NDC: | 52544-920-08 |
| Package Description: | 8 POUCH in 1 BOX (52544-920-08) > 1 PATCH in 1 POUCH (52544-920-54) > 4 d in 1 PATCH |
| NDC Code | 52544-920-08 |
| Proprietary Name | OXYTROL |
| Package Description | 8 POUCH in 1 BOX (52544-920-08) > 1 PATCH in 1 POUCH (52544-920-54) > 4 d in 1 PATCH |
| Product NDC | 52544-920 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxybutynin |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20030226 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | OXYBUTYNIN |
| Strength Number | 3.9 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |